T Cell Deletion Induced by Chronic Infection with Mouse Mammary Tumor Virus Spares a CD25-Positive, IL-10-Producing T Cell Population with Infectious Capacity

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4642-4653

  Papiernik, Martine ^a,b   Leite de Moraes, Maria Do Carmo ^a   Pontoux, Christiane ^a   Joret, Anne Marie ^a   Rocha, Benedita ^a   Penit, Claude ^a   Dy, Michel ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; SUPERANTIGEN; T LYMPHOCYTE ANTIGEN; VIRUS ANTIGEN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; PHYSIOLOGY; RETROVIRUS INFECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; CYTOKINES; GENE EXPRESSION; IMMUNE TOLERANCE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE INFECTIONS; RNA, MESSENGER; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; TUMOR VIRUS INFECTIONS;

EID: 0031570008     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
2. Kappler, J. W., U. Staerz, J. White, and P. C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332:33.
3. a-encoded antigens. Nature 332:40.
4. Tomonari, K., S. Fairchild, and O. A. Rosenwasser. 1993. Influence of viral superantigens on Vβ- and Vα-specific positive and negative selection. Immunol. Rev. 131:131.
5. Golovkina, T. V., A. Chervonsky, S. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637.
6. Ross, S. R., T. V. Golovkina, and A. Chervowsky. 1993. Superantigen function in mouse mammary tumor virus-induced tumorigenesis. In Superantigen. A Pathogene View of the Immune System. B. T. Huber and E. Palmer, eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 45.
7. Bittner, J. J. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162.
8. Bentvelzen, P., and J. H. Daams. 1969. Hereditary infections with MTV in mice. J. Natl. Cancer Inst. 43:1025.
9. b mice. J. Exp. Med. 175:453.
10. a (Mtv-7). J. Exp. Med. 175:1623.
11. Wei, W.-Z., R. Ficsor-Jacobs, S. J. Tsai, and R. Pauley. 1991. Elimination of Vβ2 bearing T-cells in BALB/c mice implanted with syngenic preneoplastic and neoplastic mammary lesions. Cancer Res. 51:3331.
12. a mice: implications for T cell development and immunity. J. Exp. Med. 169:2149.
13. b BALB/c colony infected with an exogenous mouse mammary tymor virus (MMTV, SW). J. Immunol. 151:759.
14. Le Bon, A., C. Desaymard, and M. Papiernik. 1995. Neonatal impaired response to viral superantigen encoded by MMTV(SW) and Mtv-7. Int. Immunol. 7:1897.
15. a expressing cells. Nature 339:541.
16. a a new congenic mouse strain. Transplantation 37:322.
17. Jouvin-Marche, E., P. N. Marche, and P.-A. Cazenave. 1992. Clonal deletion ov Vβ17 T cells in mice from natural populations. Semin. Immunol. 4:305.
18. Dialynas, D. P., S. Z. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK 1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
19. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
20. Payne, J., B. T. Huner, N. A. Cannon, R. Schneider, W. M. Schilham, H. Acha-Orbea, H. R. MacDonald, and H. Hengartner. 1985. Two monoclonal rat antibodies with specificity for the β-chain variable region Vβ6 of the murine T-cell receptor. Proc. Natl. Acad. Sci. USA 85:7695.
21. Staertz, U. D., and M. J. Bevan. 1986. Activation of resting T lymphocytes by a monoclonal antibody directed against an allotypic determinant on the T cell receptor. Eur. J. Immunol. 16:283.
22. a haplotypes: determination with a Vα2-specific monoclonal antibody. Eur. J. Immunol. 22:399.
23. Yokoyama, W., F. Kining, and P. Kehn. 1988. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141:369.
24. Lowenthal, J. W., P. Corthesy, C. Tougne, R. K. Lees, H. R. MacDonald, and M. Nabholz. 1985. High- and low-affinity IL-2 receptors: analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunol. 135:1808.
25. Moreau, J. L., G. Somme, A. Dautry-Varsat, and J. Thèze. 1988. Characterization of three monoclonal antibodies specifically directed against the ligand binding site area of the p55 subunit of the mouse interleukin-2 receptor. Mol. Immunol. 25:57.
26. Bluestone, J. A., D. M. Pardoll, S. O. Sharrows, and B. J. Fowlkes. 1986. Characterization of murine thymocytes with CD3-associated T-cell receptor structures. Nature 326:82.
27. Portsmann, T., T. Ternynck, and S. Avrameas. 1985. Quantification of 5-bromo-2′-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferative response. J. Immunol. Methods 82:169.
28. Penit, C., and F. Vasseur. 1993. Phenotype analysis of cycling and postcycling thymocytes: evaluation of detection methods for BrdUrd and surface proteins. Cytometry 14:757.
29. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359.
30. + T cells are a potential source of IL-4 during primary immune response. J. Immunol. 155:4544.
31. Reynaud, C.-A., B. A. Imhof, V. Anquez, and J.-C. Weil. 1992. Emergence of committed B lymphoid progenitors in the developing chicken embryo. EMBO J. 11:4349.
32. a superantigen-specific T cell response. J. Exp. Med. 175:1405.
33. Waanders, F. A., A. Lussow, and H. R. MacDonald. 1993. Skewed T cell receptor Vα repertoire among superantigen reactive murine T cells. Int. Immunol. 5:55.
34. a mice: a role for the third complementarity-determining region (CDR3) of the T cell receptor β-chain in superantigen recognition. J. Immunol. 155:4171.
35. + cells. J. Immunol. 152:4270.
36. + cytotoxic T lymphocytes via CD3-ε differs from triggering via α/β T cell receptor. CD3-ε-induced cytotoxicity occurs in the absence of protein kinase C and does not result in exocytosis of serine esterases. J. Immunol. 147:1115.
37. Mercep, M., A. M. Weissman, S. J. Frank, R. D. Klausner, and J. D. Ashwell. 1989. Activation-driven programmed cell death and T cell receptor γη expression. Science 246:1162.
38. Akridge, E. E., L. K. Oyafuso, and S. G. Reed. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:5782.
39. Masood, R., Y. Lunardi-Iskandar, T. Moudgil, Y. Zhang, R. E. Law, C. L. Huang, R. K. Puri, A. M. Levine, and P. S. Gill. 1994. IL-10 inhibits HIV-1 replication and is induced by tat. Biochtm. Biophys. Res. Commun. 202:374.
40. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and G. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest 93:768.
41. Burdin, N., N. Peronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin-10. J. Exp. Med. 177:295.
42. Taga, K., J. Chretien, B. Cherney, L. Diaz, M. Brown, and G. Tosato. 1994. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J. Clin. Invest. 94:251.
43. Gorczynski, R. M. 1995. Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell. Immunol. 160:224.
44. Bacchetta, R., M. Bigler, J.-L. Touraine, R. Parkman, P. A. Tovo, J. Abrams, R. de Waal Malefyt, J. E. de Vries, and M. G. Roncarolo. 1994. High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179:493.
45. Candolfi, E., C. A. Hunter, and J. S. Remington. 1995. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751.
46. King, C. L., S. Mahanty, V. Kumaraswami, J. S. Abrams, J. Regunathan, K. Jayaraman, E. A. Ottesen, and T. B. Nutman. 1993. Cytokine control of partasite-specitic anergy in human lymphatic filariasis: preferential induction of a regulatory T helper type 2 lymphocyte subset. J. Clin. Invest. 92:1667.
47. Flores Villaneuva, P. O., S. M. Chikunguwo, T. S. Harris, and M. J. Stadecker. 1993. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J. Immunol. 151:3192.
48. Schols, D., D. Jones, and M. G. Roncarolo. 1995. Unique cytokine production profile of anergic human T cell in SCID-hu mice after staphylococcal enterotoxin B administration. J. Immunol. 154:3204.
49. Zhang, L., R. G. Miller, and J. Zhang. 1996. Characterization of apoptosis-resistant antigen-specific T cells in vivo. J. Exp. Med. 183:2065.
50. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α-chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
51. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and T. Masaaki. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J. Immunol. 155:1151.
52. Tsubura, A., M. Inaba, S, Imai, A. Murakami, N. Oyaizu, R. Yasumizu, Y. Ohnishi, H. Tanaka, S. Morii, and S. Ikehara. 1988. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res. 48:6555.
53. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529.
54. Waanders, G. A., A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359.
55. a mice: implication for neonatal tolerance induction. Int. Immunol. 6:1899.
56. Le Bon, A., B. Lucas, F. Vasseur, C. Penit, and M. Papiernik. 1996. In vivo T cell response to viral superantigen: selective migration rather than proliferation. J. Immunol. 156:4602.
57. Raulet, D. H. 1985. Expression and function of interleukin-2 receptors on immature thymocytes. Nature 314:101.
58. Ceredig, R., J. W. Lowenthal, and M. Nabholz. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.